In Brief: FDA user fee waivers
This article was originally published in The Tan Sheet
Executive Summary
FDA user fee waivers: Waiver authority may be redelegated from Chief Mediator and Ombudsman and User Fee Waiver Officer Amanda Bryce Norton (formerly Pederson) to Deputy Mediator and Ombudsman Steven Unger and to Deputy User Fee Waiver Officer Suzanne O'Shea, FDA announces in Jan. 7 Federal Register...